Differential sensitivity to NaCl for inhibitors and substrates that recognize mutually exclusive binding sites on the neuronal transporter of dopamine in rat striatal membranes
- PMID: 11248372
- DOI: 10.1016/s0168-0102(00)00230-3
Differential sensitivity to NaCl for inhibitors and substrates that recognize mutually exclusive binding sites on the neuronal transporter of dopamine in rat striatal membranes
Abstract
Addition of NaCl (90--290 mM) to a 10 mM Na(+) medium did not significantly modify B(max) and K(d) values for [3H]mazindol binding to the dopamine neuronal transporter (DAT) studied on rat striatal membranes at 20 degrees C. Addition of NaCl differentially affected the ability of other uptake inhibitors and substrates to block the [3H]mazindol binding. Ratios of 50% inhibiting concentrations calculated for 290 and 90 mM NaCl allowed to distinguish three groups of agents: substrates which were more potent in the presence of 290 mM NaCl (group 1; ratio < 1) and two groups of uptake inhibitors displaying ratio values either ranging around two (group 2: WIN 35,428, cocaine, methylphenidate, pyrovalerone) or close to unity (group 3: BTCP, mazindol, benztropine, nomifensine). However, agents from these three groups recognize mutually exclusive binding sites since in interaction studies the presence of WIN 35,428 (group 2) or mazindol (group 3) increased the 50% inhibiting concentrations of D-amphetamine (group 1) and WIN 35,428 on the [3H]mazindol binding to theoretical values expected for a competition of all of these compounds for the same binding domain on the DAT.
Similar articles
-
Halogenated mazindol analogs as potential inhibitors of the cocaine binding site at the dopamine transporter.J Med Chem. 1996 Dec 6;39(25):4935-41. doi: 10.1021/jm960288w. J Med Chem. 1996. PMID: 8960553
-
Cations affect [3H]mazindol and [3H]WIN 35,428 binding to the human dopamine transporter in a similar fashion.J Neurochem. 1997 Sep;69(3):1106-18. doi: 10.1046/j.1471-4159.1997.69031106.x. J Neurochem. 1997. PMID: 9282933
-
Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier.Eur J Pharmacol. 1994 Nov 3;264(3):391-8. doi: 10.1016/0014-2999(94)00502-8. Eur J Pharmacol. 1994. PMID: 7698180
-
Binding of uptake blockers to the neuronal dopamine transporter: further investigation about cationic and anionic requirements.Naunyn Schmiedebergs Arch Pharmacol. 2000 Sep;362(3):213-21. doi: 10.1007/s002100000280. Naunyn Schmiedebergs Arch Pharmacol. 2000. PMID: 10997723
-
The dopamine transporter and cocaine medication development: drug self-administration in nonhuman primates.J Pharmacol Exp Ther. 2001 Jul;298(1):1-6. J Pharmacol Exp Ther. 2001. PMID: 11408518 Review.
Cited by
-
Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.Neuropsychopharmacology. 2013 Mar;38(4):552-62. doi: 10.1038/npp.2012.204. Epub 2012 Oct 17. Neuropsychopharmacology. 2013. PMID: 23072836 Free PMC article.
-
Interaction of catechol and non-catechol substrates with externally or internally facing dopamine transporters.J Neurochem. 2009 May;109(4):981-94. doi: 10.1111/j.1471-4159.2009.06034.x. Epub 2009 Mar 11. J Neurochem. 2009. PMID: 19519772 Free PMC article.
-
In vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity.Neuropsychopharmacology. 2013 Mar;38(4):563-73. doi: 10.1038/npp.2012.233. Epub 2012 Nov 8. Neuropsychopharmacology. 2013. PMID: 23212455 Free PMC article.
-
Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate.Neuropsychopharmacology. 2012 Jun;37(7):1708-16. doi: 10.1038/npp.2012.17. Epub 2012 Mar 7. Neuropsychopharmacology. 2012. PMID: 22395730 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous